63 results
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified as a financial
6-K
EX-99.2
REPCF
RepliCel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently … were classified as liability. Management was required to make estimates to determine the fair value of the components of the preference share
6-K
EX-99.2
REPCF
RepliCel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management … redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value of the components
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
at an agreed price at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management
6-K
EX-99.2
3656u
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
kvv1dy jdh4x
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.2
go3q x30vlhk
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
bzpzk i5mvap1r
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
0p6 94apsc
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
6b2g2tc 4057
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
mi41sr1w55f
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
uvcnht8pmiwk
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
8ghs1r
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
szu4k19e6 4cy
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
gpzxg8o3
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
tlk5 76wlf6g7vh0z8o
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
gorm1cu yt
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm